To continue reading this content, please enable JavaScript in your browser settings and refresh this page. In early December ...
The FDA accepted the BLA for ivonescimab plus chemotherapy for patients with EGFR-mutated non-small cell lung cancer post-TKI ...
In this phase 2 study, researchers aimed to determine whether adding elraglusib to gemcitabine and nab-paclitaxel improved survival in patients with treatment-naïve metastatic PDAC.
Amplia finished the December 2025 quarter with a cash position of $31.5 million (September 2025: $29.2 million). During the quarter, the Company had net operating cash inflows of $2.4 million in ...
A misdiagnosis of fibroid tumors led to the discovery of appendix cancer that spread to the ovary and uterus, requiring surgeries and chemotherapy. Maintaining a positive mindset and documenting ...
Could guts save your butt? A new study reports that bacteria found in the intestines of Japanese tree frogs show remarkable promise in treating colorectal cancer. A research team from the Japan ...
NASHVILLE, Tenn. (Ivanhoe Newswire) - Cancers in younger adults are surging. Colon cancer, once a midlife disease, is striking earlier than ever. Breast and kidney cancers are also climbing in people ...
INDIANAPOLIS (WISH) — Cancers in younger adults are surging. Colon cancer, once a midlife disease, is striking earlier than ever. Breast and kidney cancers are also climbing in people under 50. Now, a ...
NASHVILLE, Tenn. (Ivanhoe Newswire) - Cancers in younger adults are surging. Colon cancer, once a midlife disease, is striking earlier than ever. Breast and kidney cancers are also climbing in people ...
During and after cancer treatment with chemotherapy, up to 75 percent of people experience thinking and memory problems known as “chemo brain.” The cause of chemo rage can vary, says Dr. Cartagena, ...
What we eat plays a major role in our health and well-being, especially in the development of chronic disease. On a recent episode of Dr. Mark Hyman’s podcast, "The Dr. Hyman Show," the physician and ...